NMLSF

Restart Life Sciences Corp. NMLSF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NMLSF AGTX RGBP AGNPF PKTX EBYH STMM AXIM PSYGF NBCO
6M 64.38 % -4.95 % -78.43 % -12.52 % -59.23 % -5.59 % 0.00 % 66.67 % -71.96 % -42.97 %
YTD 75.33 % -71.88 % -76.71 % 13.37 % -46.79 % -17.69 % 0.00 % 242.11 % -49.23 % -65.24 %
1Y -17.81 % -0.20 % -91.03 % -18.01 % -46.46 % -35.80 % 0.00 % 195.45 % -39.07 % -83.78 %
3Y -82.47 % -51.08 % -99.67 % -88.63 % -82.33 % -35.02 % 0.00 % -90.14 % -30.76 % -94.41 %
5Y -96.37 % -98.19 % -95.33 % -99.03 % -94.39 % 797.15 % 0.00 % -98.98 % -85.21 % -98.72 %
10Y -94.61 % -99.67 % -99.99 % -99.70 % -87.40 % 15 950.00 % 0.00 % -98.97 % -85.21 % -99.90 %
From the beginning -99.87 % -99.60 % -99.99 % -99.70 % -98.74 % -99.68 % 0.00 % -99.94 % -85.21 % -100.00 %

Dividend